Effect of Neoadjuvant Chemotherapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells.

Trial Profile

Effect of Neoadjuvant Chemotherapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 01 May 2017

At a glance

  • Drugs Trastuzumab (Primary) ; Antineoplastics
  • Indications Breast cancer
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 01 May 2017 Results (n=48) assessing genomic characterization of HER positive breast cancer patients and its predictive role for treatment efficacy with chemotherapy and trastuzumab using patient data from NCT00513292 and NCT00353483 trials, published in the Annals of Oncology
    • 04 Aug 2011 Planned end date changed from Aug 2013 to Aug 2016 as reported by ClinicalTrials.gov.
    • 04 Jun 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top